Evidence map›Paper›PMID 39177509›Full record

ArticleJournal of magnetic resonance imaging : JMRI2025

Assessment of Tumor Cell Invasion and Radiotherapy Response in Experimental Glioma by Magnetic Resonance Elastography.

Hannah Fels-Palesandro, Sophie Heuer, Berin Boztepe, Yannik Streibel, Johannes Ungermann, Chenchen Pan, Jonas G Scheck, Manuel Fischer, Volker J Sturm, Daniel D Azorín and 12 more

Abstract read
In one paragraph

Article in Journal of magnetic resonance imaging : JMRI, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Observational
  6. Review
  7. [News on the imaging of large vessel vasculitis].Zeitschrift fur Rheumatologie · 2024
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Hannah Fels-PalesandroDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.ORCID https://orcid.org/0009-0008-9737-6958
Sophie HeuerDepartment of Neurology and National Center for Tumor Disease (NCT), Heidelberg University Hospital, Heidelberg, Germany.
Berin BoztepeDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Yannik StreibelDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Johannes UngermannDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Chenchen PanDepartment of Neurology and National Center for Tumor Disease (NCT), Heidelberg University Hospital, Heidelberg, Germany.
Jonas G ScheckDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Manuel FischerDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Volker J SturmDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Daniel D AzorínDepartment of Neurology and National Center for Tumor Disease (NCT), Heidelberg University Hospital, Heidelberg, Germany.
Kianush Karimian-JaziDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Giacomo AnnioINSERM UMRS1148 - Laboratory for Vascular Translational Science, University Paris, Paris, France.
Amir AbdollahiClinical Cooperation Unit Translational Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Ina WeidenfeldDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Wolfgang WickDepartment of Neurology and National Center for Tumor Disease (NCT), Heidelberg University Hospital, Heidelberg, Germany.
Varun VenkataramaniDepartment of Neurology and National Center for Tumor Disease (NCT), Heidelberg University Hospital, Heidelberg, Germany.
Sabine HeilandDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Frank WinklerDepartment of Neurology and National Center for Tumor Disease (NCT), Heidelberg University Hospital, Heidelberg, Germany.
Martin BendszusDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Ralph SinkusINSERM UMRS1148 - Laboratory for Vascular Translational Science, University Paris, Paris, France.
Michael O BreckwoldtDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.ORCID https://orcid.org/0000-0002-9980-2390
Katharina SchregelDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.ORCID https://orcid.org/0000-0003-4367-1667

Funding

Clinician-Scientist-Program of the University of HeidelbergDaimler und Benz Stiftung 32-97/21Deutsche Forschungsgemeinschaft 394046768Deutsche Forschungsgemeinschaft 451894423Deutsche Forschungsgemeinschaft BR 6153/1-1European Union's Horizons TMA MSCA Postdoctoral Fellowship Award 101068340ITMO Cancer Aviesan ISMRM Cancer 2020 grant DESP/PB n°241Olympia-Morata program of the Medical Faculty, University of Heidelberg
6 · The paper itself

Abstract

backgroundGliomas are highly invasive brain neoplasms. MRI is the most important tool to diagnose and monitor glioma but has shortcomings. In particular, the assessment of tumor cell invasion is insufficient. This is a clinical dilemma, as recurrence can arise from MRI-occult glioma cell invasion. HYPOTHESIS: Tumor cell invasion, tumor growth and radiotherapy alter the brain parenchymal microstructure and thus are assessable by diffusion tensor imaging (DTI) and MR elastography (MRE). STUDY TYPE: Experimental, animal model. ANIMAL MODEL: Twenty-three male NMRI nude mice orthotopically implanted with S24 patient-derived glioma cells (experimental mice) and 9 NMRI nude mice stereotactically injected with 1 μL PBS (sham-injected mice). FIELD STRENGTH/SEQUENCE: 2D and 3D T2-weighted rapid acquisition with refocused echoes (RARE), 2D echo planar imaging (EPI) DTI, 2D multi-slice multi-echo (MSME) T2 relaxometry, 3D MSME MRE at 900 Hz acquired at 9.4 T (675 mT/m gradient strength). ASSESSMENT: Longitudinal 4-weekly imaging was performed for up to 4 months. Tumor volume was assessed in experimental mice (n = 10 treatment-control, n = 13 radiotherapy). The radiotherapy subgroup and 5 sham-injected mice underwent irradiation (3 × 6 Gy) 9 weeks post-implantation/sham injection. MRI-/MRE-parameters were assessed in the corpus callosum and tumor core/injection tract. Imaging data were correlated to light sheet microscopy (LSM) and histology. STATISTICAL TESTS: Paired and unpaired t-tests, a P-value ≤0.05 was considered significant.

resultsFrom week 4 to 8, a significant callosal stiffening (4.44 ± 0.22 vs. 5.31 ± 0.29 kPa) was detected correlating with LSM-proven tumor cell invasion. This was occult to all other imaging metrics. Histologically proven tissue destruction in the tumor core led to an increased T2 relaxation time (41.65 ± 0.34 vs. 44.83 ± 0.66 msec) and ADC (610.2 ± 12.27 vs. 711.2 ± 13.42 × 10 DATA

conclusionMRE is promising for the assessment of key glioma characteristics. EVIDENCE LEVEL: NA TECHNICAL EFFICACY: Stage 2.

Indexed as

Brain NeoplasmsElasticity Imaging TechniquesGliomaMagnetic Resonance ImagingAnimalsBrainCell Line, TumorDiffusion Tensor ImagingDisease Models, AnimalHumansImaging, Three-DimensionalMaleMiceMice, NudeNeoplasm Invasivenessbrain tumorglioma invasionMR elastographystiffnesstissue biomechanicswhite matter

Identifiers

PMID39177509
PMCPMC11803692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.